ARID1A and ovarian carcinoma: Significantly better survival in the subgroup of ARID1A positive tumors could also be observed for sole analysis of all endometrioid (p = 0.039) and all ovarian carcinoma (p = 0.008) as well as tumors of grading G3 (p = 0.028).